Statement of Principles concerning renal artery atherosclerotic disease No. 33 of 1999
- F2005C00778
Superseded | View Series
No. 33 of 1999 Determinations as amended.
Statement of Principles concerning renal artery atherosclerotic disease.
Administered by: Veterans' Affairs
Prepared 25 Nov 2005 by Agency
Prepared 25 Nov 2005
Registered 01 Dec 2005
Start Date 16 Jan 2002
End Date 31 Aug 2011
Date of Ceasing: Ceased 31 Aug 2011 on the first moment of the day
Reason for Ceasing: Revoked by Statement of Principles concerning renal artery atherosclerotic disease No. 103 of 2011
Skip Navigation Links.

 

Statement of Principles

concerning

RENAL ARTERY ATHEROSCLEROTIC DISEASE

Instrument No. 33 of 1999 as amended

made under section 196B(3) of the

This compilation was prepared on 25 November 2005
taking into account
Amendment of Statement of Principles concerning RENAL ARTERY ATHEROSCLEROTIC DISEASE (Instrument No. 25 of 2002)

Prepared by the Repatriation Medical Authority Secretariat, Brisbane


Revocation and Determination

of

Statement of Principles

concerning

RENAL ARTERY ATHEROSCLEROTIC DISEASE

ICD-9-CM CODE: 440.1

 

Veterans’ Entitlements Act 1986

 

 

1.         The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a)       revokes Instrument No.40 of 1998 and Instrument No.51 of 1998; and

 

(b)       determines in their place the following Statement of Principles.

 

Kind of injury, disease or death

2.         (a)       This Statement of Principles is about renal artery atherosclerotic disease and death from renal artery atherosclerotic disease.

 

(b)       For the purposes of this Statement of Principles, “renal artery atherosclerotic disease”, means atherosclerosis of the renal arteries, causing a partial occlusion of at least 50%, or a complete occlusion of a renal artery, and together with one of the following clinical manifestations, namely poorly controlled hypertension, or renal impairment, or acute pulmonary oedema, attracting ICD-9-CM code 440.1.

 

Basis for determining the factors

3.         On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that renal artery atherosclerotic disease and death from renal artery atherosclerotic disease can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4.         Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5.         The factors that must exist before it can be said that, on the balance of probabilities, renal artery atherosclerotic disease or death from renal artery atherosclerotic disease is connected with the circumstances of a person’s relevant service are:

 

(a)       smoking at least 20 pack years of cigarettes or the equivalent thereof in other tobacco products, before the clinical onset of renal artery atherosclerotic disease; or

 

(b)       suffering from hypertension for a period of at least 10 years before the clinical onset of renal artery atherosclerotic disease; or

 

(c)       suffering from diabetes mellitus before the clinical onset of renal artery atherosclerotic disease; or

 

(d)       suffering from dyslipidaemia before the clinical onset of renal artery atherosclerotic disease; or

 

(e)       smoking at least 20 pack years of cigarettes or the equivalent thereof in other tobacco products, before the clinical worsening of renal artery atherosclerotic disease; or

 

(f)        suffering from diabetes mellitus before the clinical worsening of renal artery atherosclerotic disease; or

 

(g)       suffering from dyslipidaemia before the clinical worsening of renal artery atherosclerotic disease; or

 

(h)       being treated with a specified drug before the clinical worsening of renal artery atherosclerotic disease; or

 

(j)        inability to obtain appropriate clinical management for renal artery atherosclerotic disease.

 

Factors that apply only to material contribution or aggravation

6.         Paragraphs 5(e) to 5(j) apply only to material contribution to, or aggravation of, renal artery atherosclerotic disease where the person’s renal artery atherosclerotic disease was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Inclusion of Statements of Principles

7.         In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8.      For the purposes of this Statement of Principles:

 

“being treated with a specified drug” means being treated with any of the drugs (including where those drugs are contained in preparations) listed in the following Table of Drugs, under the circumstances as specified in the Table, with regard to the mode of administration, dose level, minimum duration of treatment, and temporality (time relationship between the last administration of the drug and the onset or worsening of the disease, as the case may be, where the administration of the drug has ceased).

 

Table of Drugs

Drug or Group of Drugs

Mode *

Dose

Minimum Duration of Treatment 

Temporality

angiotensin converting enzyme inhibitors

O

any dose

one dose

 

within 28 days immediately before

* Abbreviations:  O = oral.

 

“death from renal artery atherosclerotic disease” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s renal artery atherosclerotic disease;

 

“dyslipidaemia” generally means evidence of a persistently abnormal lipid profile after the accurate evaluation of serum lipids following a 12 hour overnight fast, and estimated on a minimum of two occasions as a:

 

(a)              total serum cholesterol level greater than or equal to 5.5 mmol/L; or

 

(b)              fasting serum triglyceride level greater than or equal to 2.0 mmol/L together with high density lipoprotein cholesterol level less than 0.9 mmol/L;

 

Note: the source for this definition is:

NHF Australia, Guide to Plasma Lipids for Doctors; Current Therapeutics, Vol 33 Supplement 1, 1992.

 


“hypertension” means:

 

(a)       a usual blood pressure reading where the systolic reading is greater than or equal to 140mmHg and/or where the diastolic reading is greater than or equal to 90mmHg; or

 

(b)       where treatment for hypertension is being administered;

 

“ICD-9-CM code” means a number assigned to a particular kind of injury or disease in the Australian Version of The International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996, copyrighted by the National Coding Centre, Faculty of Health Sciences, University of Sydney, NSW, and having ISBN 0 642 24447 2;

 

“pack years of cigarettes or the equivalent thereof, in other tobacco products” means a calculation of consumption where one pack year of cigarettes equals twenty tailor made cigarettes (being the “standard” cigarette pack contents) per day for a period of one calendar year, or

7 300 cigarettes.  One tailor made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight.  One pack year of tailor made cigarettes equates to 7 300 cigarettes, or 7.3kg of smoking tobacco by weight.  Tobacco products means either cigarettes, pipe tobacco or cigars smoked, alone or in any combination;

 

“relevant service” means:

 

(a)       eligible war service (other than operational service); or

(b)              defence service (other than hazardous service);

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

a) pneumonia;

b) respiratory failure;

c) cardiac arrest;

d) circulatory failure; or

e) cessation of brain function.

 


 

Notes to Statement of Principles concerning renal artery atherosclerotic disease (Instrument No. 33 of 1999)

The Statement of Principles concerning renal artery atherosclerotic disease (Instrument No. 33 of 1999) in force under section 196B(3) of the Veterans’ Entitlements Act 1986, as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title

Date of notification
in Gazette or FRLI registration

Date of
commencement

Application, saving or
transitional provisions

Statement of Principles concerning renal artery atherosclerotic disease (Instrument No. 33 of 1999)

12 May 1999

(see Gazette 1999, No. GN19)

12 May 1999

 

Amendment of Statement of Principles concerning renal artery atherosclerotic disease (Instrument No. 25 of 2002)

16 January 2002

(see Gazette 2002, No. GN2)

16 January 2002

 


Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted

Provision affected

How affected

Paragraph 8 – ‘diabetes mellitus’.............................

rep. Instrument  No.25 of 2002

 

Back to Top Back to Top